VivoPower PLC - Ordinary Shares (VIVO)

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Meridian Bioscience, Inc. (NasdaqGS: VIVO) to SD Biosensor, Inc. and SJL Partners LLC. Under the terms of the proposed transaction, shareholders of Meridian will receive only $34.00 in cash for each share of Meridian that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Meridian Bioscience, Inc. (NASDAQ: VIVO) to SD Biosensor, Inc. and SJL Partners LLC for $34.00 per share in cash is fair to Meridian shareholders.

CINCINNATI, OH / ACCESSWIRE / September 1, 2021 / Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. ("Magellan"), expanded the Class I recall of its LeadCare® II Blood Lead Test Kits, LeadCare Plus® Blood Lead Test Kits, and LeadCare Ultra® Blood Lead Test Kits (the "LeadCare Test Kits") for the

CINCINNATI, OH / ACCESSWIRE / August 30, 2021 / Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, announced today its participation in the H. C. Wainwright 23rd Annual Global Investment Conference. Jack Kenny, Chief Executive Officer, will pre-record a presentation that will be available on September 13, 2021 at 7:00 am ET. A link to access the pre-recorded presentation will be